PACI, Massimiliano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 459
EU - Europa 145
AS - Asia 69
OC - Oceania 1
Totale 674
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 459
GB - Regno Unito 62
SE - Svezia 25
SG - Singapore 25
IT - Italia 19
CN - Cina 17
DE - Germania 16
HK - Hong Kong 10
TR - Turchia 10
UA - Ucraina 9
BG - Bulgaria 5
FI - Finlandia 3
BE - Belgio 2
FR - Francia 2
MY - Malesia 2
VN - Vietnam 2
ID - Indonesia 1
IN - India 1
KZ - Kazakistan 1
LT - Lituania 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 674
Salva come PNG Salva come JPEG
Città #
Fairfield 84
Ashburn 55
Southend 44
Cambridge 32
Chandler 31
Seattle 29
Woodbridge 29
Wilmington 25
Houston 21
Dearborn 20
Nyköping 20
Singapore 20
Ann Arbor 19
Jacksonville 16
Modena 9
San Diego 9
Hong Kong 8
Izmir 8
Beijing 7
Princeton 5
Sofia 5
Bremen 4
Eugene 4
Falls Church 4
New York 4
Hounslow 3
Milan 3
Augusta 2
Brussels 2
Chiswick 2
Dong Ket 2
Indiana 2
London 2
Nanjing 2
Redmond 2
Shanghai 2
Belgrade 1
Bindlach 1
Bologna 1
Cheyenne 1
Chicago 1
Frankfurt am Main 1
Gambettola 1
Guangzhou 1
Helsinki 1
Jakarta 1
Kilburn 1
Kokshetau 1
Leawood 1
Monmouth Junction 1
Nagpur 1
Nutley 1
Phoenix 1
Redwood City 1
Reggio Emilia 1
Reggio Nell'emilia 1
San Antonio 1
Southwark 1
Verona 1
Washington 1
Totale 560
Salva come PNG Salva come JPEG
Nome #
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. 201
PUREAIR protocol: Randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancer 148
Placental transmogrification of the lung: Clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells 147
Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma 118
Rehabilitation for lung cancer patients undergoing surgery: results of the PUREAIR randomized trial 53
Exploring EGLN1 as a therapeutic target for KRAS mutated lung cancer: insights into mitochondrial modulation 7
The long non-coding RNA TAZ-AS202 promotes lung cancer progression via regulation of the E2F1 transcription factor and activation of Ephrin signaling 5
PHD2 (EGLN1) is a novel therapeutic target in KRAS-mutated lung carcinoma 3
Implementing an organoid platform to assess efficacy of PHD inhibitors as anti-cancer agents 3
Patient derived organoids are an useful tool to investigate Hippo pathway involvement in lung cancer 3
Totale 688
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020157 0 0 11 17 19 28 29 18 18 4 10 3
2020/2021106 12 3 9 7 16 6 4 16 5 14 7 7
2021/2022107 0 13 9 2 3 10 6 8 13 8 29 6
2022/2023100 16 9 8 5 12 16 6 9 12 0 1 6
2023/202464 3 7 2 8 16 9 2 5 0 3 2 7
2024/202534 7 16 11 0 0 0 0 0 0 0 0 0
Totale 688